Shelter Pharma
Shelter Pharma Share Price Chart
Shelter Pharma last traded at ₹53.45 (2026-10-13). Over the past month the stock moved +72.4%, three months the stock moved +68.9%, year the stock moved +20.1%. Its closing range over 52 weeks is ₹25.20 – ₹53.45, with the latest close at its 52-week high.
Closing prices up to 2026-10-13.
About Shelter Pharma
Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including food supplements for animals[1]
Business Overview:[1] SPL is a GMP & HACCP certified and ISO 9001:2015 certified manufacturer and seller of a range of herbal Ayurvedic medicines in India for humans and food supplements for animals
Fundamentals
Quarterly Results
In the latest quarter (Mar 2026), Shelter Pharma reported sales of ₹39.84 crore (+92.4%) and net profit of ₹4.53 crore (+45.2%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 39.84 | 6.47 | 16.24 | 4.53 | 2.73 |
| Sep 2025 | 33.29 | 6.26 | 18.80 | 4.50 | 3.89 |
| Mar 2025 | 26.60 | 5.18 | 19.47 | 3.70 | 3.20 |
| Sep 2024 | 24.06 | 4.90 | 20.37 | 3.54 | 3.06 |
| Mar 2024 | 20.71 | 4.29 | 20.71 | 3.12 | 2.70 |
| Sep 2023 | 19.31 | 4.29 | 22.22 | 3.10 | 2.68 |
| Mar 2023 | 19.13 | 4.31 | 22.53 | 2.81 | 3.63 |
| Sep 2022 | 17.02 | 3.31 | 19.45 | 2.40 | 49.59 |
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | +41.4% | +39.0% | +72.4% | +92.4% |
| Operating profit growth | +48.0% | +20.2% | +45.9% | +50.8% |
| Net profit growth | +47.5% | +31.7% | +45.2% | +45.2% |
| EPS growth | -93.8% | -11.8% | +45.1% | +1.1% |
| OPM % | 20.4% | 19.5% | 18.8% | 16.2% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Shelter Pharma reported sales of ₹73.13 crore (+44.4%) and net profit of ₹9.03 crore (+24.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 73.13 | 12.72 | 17.39 | 9.03 | 5.44 |
| Mar 2025 | 50.66 | 10.07 | 19.88 | 7.24 | 6.26 |
| Mar 2024 | 39.93 | 8.91 | 22.31 | 6.20 | 5.36 |
| Mar 2023 | 36.15 | 8.15 | 22.54 | 5.21 | 6.73 |
| Mar 2022 | 30.06 | 3.05 | 10.15 | 2.06 | 42.56 |
| Mar 2021 | 22.48 | 0.19 | 0.85 | 0.04 | 0.83 |
| Mar 2020 | 30.07 | 0.24 | 0.80 | 0.08 | 1.76 |
| Mar 2017 | 29.95 | -0.70 | -2.34 | 0.05 | 1.10 |
| Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +6.6% | +0.4% | -25.2% | +33.7% | +20.3% | +10.5% | +26.9% | +44.4% |
| Operating profit growth | -566.7% | – | -20.8% | +1505.3% | +167.2% | +9.3% | +13.0% | +26.3% |
| Net profit growth | +0.0% | +60.0% | -50.0% | +5050.0% | +152.9% | +19.0% | +16.8% | +24.7% |
| EPS growth | +0.0% | +60.0% | -52.8% | +5027.7% | -84.2% | -20.4% | +16.8% | -13.1% |
| OPM % | -2.3% | 0.8% | 0.9% | 10.2% | 22.5% | 22.3% | 19.9% | 17.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Shelter Pharma.
Get Free AI Stock Analysis FREE →Latest News
-
Shelter Pharma regularizes Vinita Gadhavi as independent director - scanx.trade
-
Shelter Pharma spurts on bagging export order worth $12,285 from Genet International - Business Standard
-
Shelter Pharma Bags Verka Dairy Order; Shares Fall 1.85%
-
Shelter Pharma begins dispatch of $141,600 export order for Joemega Capsules
-
Shelter Pharma gets GMP Certificate from Food & Drugs Control Administration
-
Shelter Pharma receives renewal manufacturing licence for Himatnagar facility
-
Shelter Pharma receives renewal manufacturing licence for Himatnagar facility
-
Shelter Pharma receives renewal manufacturing licence for Himatnagar facility
-
Shelter Pharma moves up on bagging repeat purchase orders from Taha Drugs & Chemicals Co
-
Shelter Pharma Secures Repeat International Purchase Orders Worth USD 84,450 from Taha Drugs & Chemicals - scanx.trade
Frequently Asked Questions
What is Shelter Pharma's current stock price?
Shelter Pharma shares were last quoted at ₹53.45 (+19.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Shelter Pharma?
Shelter Pharma has a price-to-earnings (P/E) ratio of 6.90 and a price-to-book (P/B) ratio of 0.86. The industry P/E is 53.33.
What is the 52-week high and low of Shelter Pharma?
The 52-week high of Shelter Pharma is ₹46.51 and the 52-week low is ₹23.00.
What is the market cap of Shelter Pharma?
The market capitalisation of Shelter Pharma is about ₹62.30 crore.
How did Shelter Pharma perform in its latest quarterly results?
In the latest quarter (Mar 2026), Shelter Pharma reported sales of ₹39.84 crore (+92.4%) and net profit of ₹4.53 crore (+45.2%), compared with the same quarter last year.
Is Shelter Pharma a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Shelter Pharma has a 3-year ROE of 18.00%, 3-year profit growth of 15.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Shelter Pharma?
Promoters hold about 44.38% of Shelter Pharma.
Which sector does Shelter Pharma belong to?
Shelter Pharma belongs to the Pharmaceuticals & Drugs sector.